Andrew Craven, M.S. has extensive work experience in the field of scientific research. Andrew is currently working as an Associate Scientist at Initial Therapeutics since 2022. Prior to this, they worked at Zai Lab as a Scientist from 2020 to 2022.
Before joining Zai Lab, Andrew held the position of Senior Research Associate at Genentech from 2019 to 2020. In this role, they were responsible for producing lentivirus and AAV CRISPR libraries for the entire GRED research division. Andrew also successfully developed AAV production and purification in 293 HEK cell and baculovirus contexts, which was a novel achievement for Genentech in-house.
Andrew also gained valuable experience as a Senior Research Associate at Zymergen from 2018 to 2019 and Circuit therapeutics, Inc. from 2015 to 2018. Andrew started their career as an Associate Scientist at Avalanche Biotechnologies, Inc. from 2014 to 2015.
Furthermore, Andrew has experience working as an Applications Scientist at Consultant Example: Paramount Farms from 2007 to 2014. During their time there, they proposed and obtained funding for theories related to processing bleaches and pistachio-based fungal toxins. Their research resulted in multiple scientific publications and collaborations with international labs, ultimately leading to an increase in sales in the Chinese pistachio market.
Prior to their role at Paramount Farms, Andrew worked as a Microbial Scientist at Paramount Farms from 2005 to 2007. Andrew also gained experience as a Genetic Analysis Technical Support Specialist at APPLIED BIOSYSTEMS from 2002 to 2005 and as an Associate Scientist at Cytokinetics from 1999 to 2002.
Overall, Andrew Craven, M.S. has a diverse work experience in scientific research, with a strong track record of accomplishments and contributions to various organizations.
Andrew Craven, M.S. obtained their Bachelor's Degree in Biology from the University of California, Riverside in 1991. Andrew then pursued their Master of Science in Molecular Biology from San Diego State University, which they completed in 1999.
Sign up to view 0 direct reports
Get started